| MolName | (E)-N-[5-[(2,5-dioxopyrrolidin-1-yl)methyl]-1,3,4-oxadiazol-2-yl]-3-phenylprop-2-enamide |
| MolecularFormula | C16H14N4O4 |
| Smiles | O=C(/C=C/c1ccccc1)Nc1nnc(CN(C(CC2)=O)C2=O)o1 |
| InChI | InChI=1S/C16H14N4O4/c21-12(7-6-11-4-2-1-3-5-11)17-16-19-18-13(24-16)10-20-14(22)8-9-15(20)23/h1-7H,8-10H2,(H,17,19,21) |
| InChIK | KOTKWFXXZUHHFG-UHFFFAOYSA-N |
| TotalMolweight | 326.311 |
| Molweight | 326.311 |
| MonoisotopicMass | 326.101506 |
| CLogP | 0.8589 |
| CLogS | -2.801 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 249.52 |
| Relative PSA | 0.36141 |
| PolarSurfaceArea | 105.4 |
| Druglikeness | -2.0362 |
| Mutagenic | none |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.625 |
| Fragments | 1 |
| Non HAtoms | 24 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| Rotatable Bond | 5 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 11 |
| Sp3Atoms | 3 |
| Symmetricatoms | 5 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon |
Click to Load Molecule:
1 - (E)-N-[5-[(2,5-dioxopyrrolidin-1-yl)methyl]-1,3,4-oxadiazol-2-yl]-3-phenylprop-2-enamide | 2 - (E)-N-[5-[(2,5-dioxopyrrolidin-1-yl)methyl]-1,3,4-oxadiazol-2-yl]-3-phenylprop-2-enamide